Examination of the level of insulin antagonist hormones in hyperglycemic emergencies on admission.
Not Applicable
- Conditions
- diabetes mellitus
- Registration Number
- JPRN-UMIN000046105
- Lead Sponsor
- Kitasato University, School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 27
Inclusion Criteria
Not provided
Exclusion Criteria
1) A woman who is in lactation period or who may be pregnant.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the levels of insulin counter hormone (glucagon, catecholamine, growth hormone, and cortisol) on admission.
- Secondary Outcome Measures
Name Time Method the levels of insulin, plasma glucose, hemoglobin A1c (HbA1c), glycated albumin (GA), C-peptide, glucagon-like peptide 1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), BUN and ketone body on admission